Washington Trust Advisors’s Idexx Laboratories IDXX Stock Holding History

Washington Trust Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05K	Buy	+2	New	+$1.12K	﹤0.01%	694
2025 Q2	–	Sell	-10	Closed	-$4.38K	–	642
2025 Q1	$4.38K	Buy	+10	New	+$4.34K	﹤0.01%	561
2024 Q4	–	Sell	-22	Closed	-$11.2K	–	671
2024 Q3	$11.2K	Sell	22 -102	-82%	-$49.6K	﹤0.01%	465
2024 Q2	$60.6K	Buy	124 +40	+48%	+$20.1K	0.01%	297
2024 Q1	$45.6K	Hold	84	–	–	﹤0.01%	322
2023 Q4	$46.7K	Sell	84 -20	-19%	-$9.39K	﹤0.01%	318
2023 Q3	$45.6K	Buy	104 +18	+21%	+$8.98K	﹤0.01%	314
2023 Q2	$43.2K	Buy	86 +13	+18%	+$6.23K	﹤0.01%	308
2023 Q1	$36.5K	Sell	73 -19	-21%	-$9.09K	﹤0.01%	344
2022 Q4	$37.5K	Sell	92 -209	-69%	-$81.1K	﹤0.01%	339
2022 Q3	$98K	Buy	301 +31	+11%	+$11.4K	0.01%	280
2022 Q2	$95K	Sell	270 -16	-6%	-$6.52K	0.01%	299
2022 Q1	$156K	Buy	286 +212	+286%	+$112K	0.01%	273
2021 Q4	$49K	Buy	+74	New	+$46.5K	﹤0.01%	481

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Washington Trust Advisors's IDXX Position: Q2 2026 in Review

Washington Trust Advisors opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 2 shares worth $1.05K. The stake represents ﹤0.01% of the portfolio and ranks #694 among its holdings. This is a return to the name: Washington Trust Advisors previously reported a position in IDXX as recently as Q1 2025.

Washington Trust Advisors first reported a position in IDXX in Q4 2021 and has held it in 14 quarters since. The position peaked at $156K in Q1 2022. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Washington Trust Advisors held 2 shares of Idexx Laboratories worth $1.05K as of Q2 2026.
Idexx Laboratories was a new Washington Trust Advisors position in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #694 holding.
Washington Trust Advisors first reported a position in Idexx Laboratories in Q4 2021 and has held it in 14 quarters since.
Washington Trust Advisors's Idexx Laboratories position peaked at $156K in Q1 2022.
1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.